Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 1906

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 9
Chunk 1906
---
000 shares of Common Stock, $0.0001 par value. 

As of December 31, 2024, there were 2,155,000 shares
of Common Stock outstanding, excluding 164,752 shares of common stock subject to possible redemption that are reflected in temporary
equity in the consolidated balance sheets. As of December 31, 2023, there were 2,155,000 shares of Common Stock outstanding,
excluding 3,467,954 shares of common stock subject to possible redemption that are reflected in temporary equity in the consolidated
balance sheets.

Common stockholders of record are entitled to
one vote for each share held on all matters to be voted on by stockholders.

F-21

OSR HOLDINGS, INC.

(f/k/a Bellevue Life Sciences Acquisition Corp.) 

NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024

Warrants 

As of December 31,
2024 and 2023, there were 7,330,000 Warrants outstanding. The Warrants that are a part of the Units (the “Warrants”)
may be exercised at a price of $11.50 per share, subject to adjustment as described in this prospectus. The Public Warrants will
become exercisable on 30 days after the completion of a Business Combination.

The Warrants have an
exercise price of $11.50 per share and will expire five years after the completion of a Business Combination or earlier
upon redemption or liquidation. Redemption of warrants when the price per Common Stock equals or exceeds $16.50. Once the Warrants become
exercisable, the Company may call the Warrants for redemption:

    ●
    in whole and not in part;

    ● at a price of $0.01 per Warrant;

    ● upon not less than 30 days’ prior written notice of redemption given after the Warrants become exercisable;

    ●  if, and only if, the reported last sale price of the Common Stock equals or exceeds $16.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the Warrants become exercisable and ending three business days before the date on which the Company sends the notice of redemption to the